Latest News on BTSG

Financial News Based On Company


Advertisement
Advertisement

BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $79.65, Implies 32% Upside

https://www.tradingview.com/news/tradingview:8d00fc5eac3b4:0-brightspring-health-services-inc-stock-12-month-price-target-raised-to-79-65-implies-32-upside/
BrightSpring Health Services, Inc. (BTSG) has seen its average 12-month price target increased by analysts from $78.94 to $79.65, with forecasts ranging from $70 to $90 per share. This updated target suggests a potential upside of approximately 32% based on the Oct. 29 closing price. The consensus rating from 20 covering analysts remains a "Buy," with no Holds or Sells.

BrightSpring Health Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/10/62740395/brightspring-health-q3-2026-earnings-call-transcript
BrightSpring Health reported strong Q3 2026 financial results, with revenue increasing 26% year-over-year to $4.2 billion and adjusted EBITDA rising 42% to $228 million. Both Pharmacy Solutions and Provider Services segments showed significant growth, driven by new LDD launches, operational efficiencies, and successful integration of acquisitions. The company projects continued robust organic adjusted EBITDA growth of 15%-20% in 2027 and is actively evaluating further acquisition opportunities while investing in AI and technology to enhance services.

BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance

https://www.streetinsider.com/Earnings/BrightSpring+Health+Services%2C+Inc.+%28BTSG%29+Tops+Q3+EPS+by+34c+%3B+Offers+Guidance/27260975.html
BrightSpring Health Services, Inc. (BTSG) reported strong Q3 earnings, surpassing analyst estimates by $0.34 with an EPS of $0.54. The company also announced revenue of $4.21 billion for the quarter and provided optimistic FY2026 revenue guidance ranging from $15.9 to $16.12 billion, exceeding the consensus of $15.36 billion.

BrightSpring Health stock soars 7% on strong earnings beat

https://www.investing.com/news/earnings/brightspring-health-stock-soars-7-on-strong-earnings-beat-93CH-4986532
BrightSpring Health Services, Inc. (NASDAQ:BTSG) reported third-quarter results that significantly exceeded analyst expectations, leading to a 6.73% surge in pre-market trading. The company's adjusted EPS of $0.54 and revenue of $4.21 billion surpassed consensus estimates, driven by strong performance in both its pharmacy and provider services segments. BrightSpring also raised its full-year 2026 revenue guidance to $15.9 billion to $16.12 billion and adjusted EBITDA guidance to $850 million to $860 million.

BrightSpring Health Services, I (BTSG) Stock forecasts

https://sg.finance.yahoo.com/research/reports/ARGUS_6751_QuantitativeReport_1792540800000/
Argus has lowered its target price for BrightSpring Health Services Inc (BTSG) to $69.00, while the current price stands at $60.86. BrightSpring Health Services is described as a home and community-based healthcare services platform providing pharmacy and provider services to complex patients. The report was issued on October 21, 2026.
Advertisement

Missed BrightSpring’s 100% Run? What Holders Had To Believe

https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/missed-brightsprings-100-run-what-holders-had-to-believe/amp
BrightSpring Health Services (NasdaqGS:BTSG) saw its stock price nearly double over the past year, returning 99.8% including dividends. This article reviews the bullish and bearish arguments that investors had to weigh a year ago, highlighting how the company's Q2 2026 results, with increased revenue and improved net margin, moved it closer to the bullish thesis. Despite the strong performance, ongoing concerns like labor costs and a high P/E ratio still present risks.

(BTSGU) Movement Within Algorithmic Entry Frameworks

https://news.stocktradersdaily.com/news_release/90/BTSGU_Movement_Within_Algorithmic_Entry_Frameworks_101926015602_1792432562.html
This analysis for Brightspring Health Services Inc. Tangible Equity Unit (NASDAQ: BTSGU) highlights a critical juncture where support is being tested. Despite weak near-term sentiment, the stock presents an exceptional 47.3:1 risk-reward setup, targeting a 13.6% gain against 0.3% risk. The report provides specific entry and exit points for various trading strategies, indicating prevailing positive sentiment and strong mid-to-long-term outlooks.

BofA Securities Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $79

https://www.moomoo.com/news/post/1001150602/bofa-securities-maintains-brightspring-health-services-btsgus-with-buy-rating
BofA Securities has reiterated its Buy rating on BrightSpring Health Services (BTSG.US) and increased its target price for the stock to $79. This adjustment reflects the firm's continued confidence in the company's performance and future outlook.

6 Green Days In A Row: BrightSpring Health Services Stock Is Up 15%

https://www.trefis.com/stock/btsg/articles/617923/6-green-days-in-a-row-brightspring-health-services-stock-is-up-15/2026-10-08
BrightSpring Health Services (BTSG) stock has experienced a significant 6-day winning streak, increasing by 14.6% and adding approximately $1.7 billion to its market value. The stock is currently 12.5% below its 52-week high but 125.0% above its 52-week low. While the broader market (S&P 500) only gained 1.7% during this period, BrightSpring's fundamentals show mixed signals with strong revenue growth but lower operating margins compared to its peers.

Why BrightSpring Health Services (BTSG) Stock Is Up Today

https://markets.financialcontent.com/stocks/article/stockstory-2026-10-2-why-brightspring-health-services-btsg-stock-is-up-today
Shares of BrightSpring Health Services (NASDAQ: BTSG) rose 4.8% after BMO Capital analyst Sean Dodge reiterated an Outperform rating and a $70 price target. This re-affirms analyst confidence in the company's long-term outlook, despite the stock being volatile and having previously dropped 17.5% two months ago after strong Q2 results and raised guidance led to a "sell-the-news" reaction due to valuation concerns. The stock is up 56.3% year-to-date and an initial $1,000 IPO investment would now be worth $5,455.
Advertisement

BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026

https://finance.yahoo.com/healthcare/articles/brightspring-health-services-inc-announce-120500593.html
BrightSpring Health Services, Inc. (NASDAQ: BTSG) will release its third-quarter 2026 financial results on Friday, October 30, 2026, before an 8:30 a.m. ET earnings conference call. The company provides home and community-based health solutions across all 50 states. Investors can register for the call or access the webcast and related materials on BrightSpring's investor relations website.

Is BrightSpring Health Services (BTSG) Cheap After Raising 2026 Guidance?

https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/is-brightspring-health-services-btsg-cheap-after-raising-202
BrightSpring Health Services (BTSG) recently raised its 2026 guidance, boosting its share price and leading to a "20% Undervalued" narrative with a fair value of $70.59. The company's core business, generating 80% of revenue, lies in specialty and institutional pharmacy services, characterized by low churn and recurring revenue due to medically sensitive treatment and complex logistics. Despite this positive outlook, the company faces risks related to U.S. government reimbursement policies which could impact its profitability.

Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?

https://www.tradingview.com/news/zacks:7c95bbf66094b:0-will-m-a-be-the-next-growth-factor-as-btsg-s-cash-flow-and-leverage-improve/
BrightSpring Health Services (BTSG) demonstrated significant financial improvement in Q2 2026, with increased operating cash flow and reduced leverage. This strengthened financial position is expected to enhance the company's ability to pursue strategic mergers and acquisitions (M&A) to drive future growth. While management emphasizes disciplined valuation, they are actively looking to expand their M&A team and pipeline, focusing on tuck-in and geographically adjacent acquisitions.

BrightSpring Health Services (BTSG) Could Be 14% Undervalued After Earnings Optimism

https://finance.yahoo.com/markets/stocks/articles/brightspring-health-services-btsg-could-021647788.html
BrightSpring Health Services (BTSG) is gaining attention due to strong quarterly performance, long-term revenue growth, and a 9% uplift in earnings expectations, earning it a Zacks Rank #1. Despite a recent 15.95% decline, the stock has seen significant year-to-date and 1-year returns of 58.59% and 156.64% respectively. The company's narrative fair value of $70.59 suggests it is currently undervalued at its last close of $60.90, largely driven by its specialty and institutional pharmacy services, which account for about 80% of its revenue and create a structural moat due to low churn and recurring revenue.

Senior Health, Home Health & Hospice Stocks Q2 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Best of the Bunch

https://www.tradingview.com/news/stockstory:31e567103094b:0-senior-health-home-health-hospice-stocks-q2-earnings-brightspring-health-services-nasdaq-btsg-best-of-the-bunch/
BrightSpring Health Services (NASDAQ:BTSG) emerged as the top performer among senior health, home health, and hospice stocks in Q2 earnings, exceeding analyst revenue and EPS estimates. Chemed (CHE) also reported a strong quarter, while AdaptHealth (AHCO) showed the weakest performance with significant misses on expectations and guidance. The industry faces both tailwinds from an aging population and headwinds from labor shortages and regulatory uncertainty.
Advertisement

Chase Investment Counsel Corp Invests $13.71 Million in BrightSpring Health Services, Inc. $BTSG

https://www.marketbeat.com/instant-alerts/filing-chase-investment-counsel-corp-invests-1371-million-in-brightspring-health-services-inc-btsg-2026-08-17/
Chase Investment Counsel Corp has invested $13.71 million in BrightSpring Health Services (NASDAQ:BTSG) by purchasing 196,648 shares in the second quarter, making it their 8th largest position. Other institutional investors have also made significant changes to their holdings in the company. BrightSpring Health Services has received numerous "Buy" ratings from analysts, with an average price target of $70.71, and recently reported strong quarterly earnings exceeding analyst expectations.

Avoiding Lag: Real-Time Signals in (BTSG) Movement

https://news.stocktradersdaily.com/news_release/98/Avoiding_Lag:_Real-Time_Signals_in_BTSG_Movement_081526010602_1786813562.html
This article provides a real-time analysis of Brightspring Health Services Inc. (NASDAQ: BTSG), highlighting weak near and mid-term sentiment but a strong long-term positive outlook. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis, noting support and resistance levels.

BrightSpring Health Services Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Revenue Outlook

https://www.moomoo.com/news/post/73898196/brightspring-health-services-q2-adjusted-earnings-revenue-rise-lifts-2026?futusource=news_newspage_recommend
BrightSpring Health Services reported an increase in Q2 adjusted earnings and revenue. The company's adjusted EBITDA grew by 17.5% year-over-year to $188 million, while net revenue rose by 14.1% to $2.3 billion. Based on these strong results and acquisition activity, BrightSpring has raised its full-year 2026 revenue outlook to $10.6 billion-$10.8 billion.

Enterprise value to revenue forward of BrightSpring Health Services, Inc. - Tangible Equity – NASDAQ:BTSGU

https://www.tradingview.com/symbols/NASDAQ-BTSGU/financials-statistics-and-ratios/enterprise-value-sales-fwd/
The article focuses on the enterprise value to revenue forward of BrightSpring Health Services, Inc. (NASDAQ: BTSGU). It highlights the company's financial overview on TradingView, stating that the market for this stock is currently closed with no trades. The content briefly mentions the data providers for market and reference data.

Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY)

https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2552375/analysts-are-bullish-on-these-healthcare-stocks-brightspring-health-services-inc-btsg-relay-therapeutics-rlay/
Analysts are showing bullish sentiment towards several healthcare stocks, including BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY), and Krystal Biotech (KRYS). TD Cowen analysts maintained Buy ratings for all three, with specific price targets and a "Strong Buy" consensus for each company based on TipRanks data. Goldman Sachs also initiated coverage on BrightSpring Health Services with a Buy rating.
Advertisement

BrightSpring Appoints AI Expert Nigam Shah to Board

https://www.theglobeandmail.com/investing/markets/stocks/BTSG-Q/pressreleases/2458211/brightspring-appoints-ai-expert-nigam-shah-to-board/
BrightSpring Health Services, Inc. has expanded its board of directors with the appointment of Dr. Nigam H. Shah, a Stanford professor and healthcare data expert. Dr. Shah, known for his work in AI, data science, and clinical informatics, will also sit on the Board's Quality and Compliance Committee. This move aims to integrate deep AI and data expertise into BrightSpring's governance, reinforcing its strategy to leverage technology for improved patient outcomes and a stronger competitive position in healthcare.

BrightSpring (BTSG) director Nigam Shah granted 4,013 RSUs in 2026

https://www.stocktitan.net/sec-filings/BTSG/form-4-bright-spring-health-services-inc-insider-trading-activity-2bb4de26cbee.html
BrightSpring Health Services director Nigam H. Shah was granted 4,013 Restricted Stock Units (RSUs) on June 11, 2026, as part of his compensation. These RSUs fully vest on the earlier of June 11, 2027, or the day before the company's 2027 annual meeting of stockholders, and each represents one share of common stock upon settlement. Following this grant, Shah directly holds 4,013 shares of BrightSpring common stock.

Stanford AI doctor Nigam Shah joins BrightSpring board, Quality Committee

https://www.stocktitan.net/news/BTSG/bright-spring-health-services-inc-welcomes-dr-nigam-h-shah-to-board-yil4b41rbknr.html
BrightSpring Health Services (NASDAQ:BTSG) has appointed Dr. Nigam H. Shah, a Stanford professor and AI expert, to its Board of Directors and the Quality and Compliance Committee, effective June 11, 2026. Dr. Shah, known for his work in applying AI and data science to improve healthcare outcomes, brings extensive experience from Stanford Healthcare and various co-founded companies. His addition aims to leverage technology and artificial intelligence to drive better solutions for patients and address healthcare challenges.

BrightSpring Health Services appoints Stanford professor to board

https://www.investing.com/news/company-news/brightspring-health-services-appoints-stanford-professor-to-board-93CH-4739517
BrightSpring Health Services has appointed Dr. Nigam H. Shah, a Stanford University professor specializing in biomedical data science and clinical AI, to its Board of Directors as a Class III member. Dr. Shah, who will also serve on the Quality and Compliance Committee, brings extensive experience in applying technology and data insights to healthcare. BrightSpring, a provider of home and community-based health services, has shown significant growth with shares surging 192% over the past year.

BrightSpring (BTSG) insider exercises options and sells 260,000 shares

https://www.stocktitan.net/sec-filings/BTSG/form-4-bright-spring-health-services-inc-insider-trading-activity-2246453da700.html
BrightSpring Health Services director Jon B. Rousseau exercised stock options for 260,000 shares at $6.37 per share and subsequently sold the same number of shares at $58.75 per share. These transactions, which included sales by The Margaret Rousseau Children Trust under a registered public offering, resulted in a net share sale of 260,000. Following these actions, Rousseau still holds significant direct and indirect interests in the company, including 1,194,503 common shares and options for 377,602 underlying shares.
Advertisement

BrightSpring (NASDAQ: BTSG) executive exercises 35K options, sells 35K shares in offering

https://www.stocktitan.net/sec-filings/BTSG/form-4-bright-spring-health-services-inc-insider-trading-activity-e076ddd5fdc3.html
Lisa A. Nalley, an executive at BrightSpring Health Services, Inc. (NASDAQ: BTSG), exercised 35,000 stock options at $6.37 per share and subsequently sold 35,000 shares in a registered public offering at $58.75 per share on June 5, 2026. This transaction allowed Nalley to convert her option-based compensation into cash while retaining a significant equity stake of 131,948 common shares and 41,909 vested stock options. The activity is described as routine liquidity management rather than a change in investment thesis.

KKR-affiliated entities sell $857.5m in BrightSpring Health stock

https://m.investing.com/news/insider-trading-news/kkraffiliated-entities-sell-8575m-in-brightspring-health-stock-93CH-4729321?ampMode=1
KKR-affiliated entities, including founding partners Henry R. Kravis and George R. Roberts, have sold approximately $857.5 million worth of BrightSpring Health Services (NASDAQ:BTSG) common stock. This significant sale follows a 144% surge in BrightSpring shares over the past year and an InvestingPro analysis suggesting the stock is overvalued. Despite analyst upgrades from Morgan Stanley and BMO Capital, the stock saw a decline after the announcement of a secondary offering.

Brightspring Health Services stock hits all-time high at 54.69 USD

https://ng.investing.com/news/company-news/brightspring-health-services-stock-hits-alltime-high-at-5469-usd-93CH-2495422
Brightspring Health Services (BTSG) stock has reached an all-time high of $54.69, marking a 137.51% increase over the past year. This surge follows strong investor confidence, a market capitalization of $10.86 billion, and impressive revenue growth of 28% over the last twelve months. The company also reported first-quarter 2026 earnings that significantly surpassed expectations, leading analysts to raise price targets.

BrightSpring Health Services (BTSG) Is Up 5.6% After Raising Revenue Guidance On Specialty Pharmacy Strength - Has The Bull Case Changed?

https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/brightspring-health-services-btsg-is-up-56-after-raising-rev/amp
BrightSpring Health Services (BTSG) reported strong first-quarter results, exceeding expectations and raising full-year revenue and EBITDA guidance due to specialty pharmacy growth and recent home health acquisitions. The company's investment narrative centers on scaling its integrated home and community care platform profitably while managing financial risks. Despite the positive outlook and a new buyback authorization, investors are cautioned to consider potential challenges like rising wage pressure and funding concentration.

BrightSpring Health Services (BTSG) Profitability Turnaround Tests Bullish Growth Narrative

https://www.sahmcapital.com/news/content/brightspring-health-services-btsg-profitability-turnaround-tests-bullish-growth-narrative-2026-05-02
BrightSpring Health Services (BTSG) reported strong Q4 2025 revenues of US$3.6 billion and a positive EPS of US$0.24, marking a significant profitability turnaround from previous losses. While analysts are optimistic about future growth in specialty pharmacy and rare drug markets, the company's high P/E ratio of 101x and significant debt, with weak interest coverage, raise concerns for cautious investors. The article highlights a large discount to DCF fair value but warns that financial leverage and thin profit margins may constrain equity holder benefits.
Advertisement

Brightspring Health earnings up next: Can specialty sustain?

https://m.uk.investing.com/news/earnings/brightspring-health-earnings-up-next-can-specialty-sustain-93CH-4641979?ampMode=1
Brightspring Health Services Inc. is set to report first-quarter earnings, with analysts expecting a sequential decline in EPS. Investors will closely watch specialty pharmacy momentum, progress toward organic EBITDA growth targets, and margin expansion within Provider Services. The earnings report will determine if the company can sustain its recent rally and bullish narrative.

BrightSpring before Q1 earnings: Buy, sell or hold the stock now?

https://www.msn.com/en-us/money/topstocks/brightspring-before-q1-earnings-buy-sell-or-hold-the-stock-now/ar-AA21VRLx
This article evaluates BrightSpring's stock performance ahead of its Q1 earnings report. It advises investors on whether to buy, sell, or hold the stock based on current trends and market predictions.

BrightSpring Health Services, Inc. (BTSG) Is Attractively Priced Despite Fast-paced Momentum

http://www.msn.com/en-us/money/topstocks/brightspring-health-services-inc-btsg-is-attractively-priced-despite-fast-paced-momentum/ar-AA1EpmkO?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c
BrightSpring Health Services, Inc. (BTSG) is identified as an attractively priced stock, despite recently experiencing fast-paced momentum. The article highlights key factors to consider for potential investors, including valuation, growth expectations, and analyst revisions. It suggests that if the company can maintain its growth, the current price offers an appealing entry point.

Wells Fargo Maintains BrightSpring Health Services (BTSG) Overweight Recommendation

https://www.msn.com/en-us/money/companies/wells-fargo-maintains-brightspring-health-services-btsg-overweight-recommendation/ar-AA1QkRyd?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c
Wells Fargo has reiterated its Overweight rating for BrightSpring Health Services (BTSG). This indicates the firm's positive outlook on the company's stock performance. The maintenance of this rating suggests continued confidence in BrightSpring Health Services by Wells Fargo.

BrightSpring Health Services (BTSG) price target increased by 18.29% to 53.65

http://www.msn.com/en-us/money/companies/brightspring-health-services-btsg-price-target-increased-by-1829-to-5365/ar-AA1Zx0eS?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c
The price target for BrightSpring Health Services (BTSG) has been increased by 18.29% to $53.65. This adjustment reflects an updated valuation for the company's stock.
Advertisement

Recent price trend in BrightSpring Health Services, Inc. (BTSG) is your friend, here's why

http://www.msn.com/en-us/money/topstocks/recent-price-trend-in-brightspring-health-services-inc-btsg-is-your-friend-heres-why/ar-AA20qUOh?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c
The article discusses how the recent price trend of BrightSpring Health Services, Inc. (BTSG) indicates that the stock is a buy. It highlights that the 200-day simple moving average (SMA) suggests strong upside potential, while the more sensitive 50-day SMA is showing early signs of a bullish cross. Investors are advised to consider the stock based on these technical indicators.

BrightSpring Health Services (BTSG) price target increased by 18.29% to 53.65

http://www.msn.com/en-us/money/companies/brightspring-health-services-btsg-price-target-increased-by-18-29-to-53-65/ar-AA1Zx0eS?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1
BrightSpring Health Services (BTSG) recently saw its price target raised by 18.29%, bringing it to $53.65. This adjustment reflects an updated outlook from analysts regarding the company's valuation.

Does BrightSpring (BTSG) Have the Leadership and Strategy to Deliver Its Organic EBITDA Ambitions?

https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/does-brightspring-btsg-have-the-leadership-and-strategy-to-d
BrightSpring Health Services confirmed the resignation of Robert Barnes, President of ResCare Community Living, unrelated to operations. This comes as BrightSpring outlined ambitious long-term organic EBITDA growth targets (15-20% through 2028) at its investor day, driven by Infusion and Home & Community growth, AI efficiencies, and M&A. Investors should consider these growth prospects against the company's high leverage and sensitivity to interest costs.

BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026

https://www.sahmcapital.com/news/content/brightspring-health-services-inc-to-announce-first-quarter-2026-financial-results-on-may-1-2026-2026-04-07
BrightSpring Health Services, Inc. (NASDAQ: BTSG) announced it will release its first quarter 2026 financial results on Friday, May 1, 2026. The company will host an earnings conference call at 8:30 a.m. ET on the same day, with registration and webcast access available through its investor relations website. BrightSpring provides home- and community-based health solutions, serving over 450,000 customers daily across all 50 states.

Leerink Maintains Outperform on BrightSpring Health Services (BTSG) March 2026

https://meyka.com/blog/leerink-maintains-outperform-on-brightspring-health-services-btsg-march-2026-0204/
Leerink Partners has maintained an "Outperform" rating on BrightSpring Health Services (BTSG) following the company's Investor Day on March 18, 2026. This reaffirmation signals continued analyst confidence from the healthcare-focused firm, though no new public price target was issued. Despite the maintained positive rating, BTSG shares experienced a slight short-term decline.
Advertisement

Did BrightSpring’s Push into Acquisitions and High-Population CON States Just Shift Its (BTSG) Investment Narrative?

https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/did-brightsprings-push-into-acquisitions-and-high-population/amp
BrightSpring Health Services (BTSG) is actively pursuing acquisitions and expansions in high-population, certificate-of-need states, aiming for geographic density and capital-efficient growth. While this strategy could reshape its investment narrative, promising substantial revenue and earnings growth, it also introduces risks such as higher debt, integration challenges, and reimbursement dependence. Investors are urged to consider these factors alongside optimistic analyst forecasts suggesting a significant upside to its current price.

5 Relative Price Strength Picks for Choppy Market Phases

https://www.tradingview.com/news/zacks:6883c4347094b:0-5-relative-price-strength-picks-for-choppy-market-phases/
In a volatile market influenced by global events and mixed economic signals, identifying stocks with strong relative price strength is crucial. This article highlights five companies – The Allstate Corporation (ALL), Five Below (FIVE), Archrock (AROC), BrightSpring Health Services (BTSG), and The Beachbody Company (BODI) – that exhibit strong fundamentals and have outperformed the S&P 500, making them potentially lucrative investments during choppy market phases. The selection process involved specific screening parameters like Zacks Rank #1, positive estimate revisions, current price above $5, high trading volume, and favorable VGM scores.

A Look At BrightSpring Health Services (BTSG) Valuation After Analyst Upgrades And Specialty Pharmacy Growth Plans

https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/a-look-at-brightspring-health-services-btsg-valuation-after-3/amp
BrightSpring Health Services (BTSG) has seen increased investor attention following its presentation at the Leerink Global Healthcare Conference, where it discussed efficiency efforts and specialty pharmacy growth. Analysts have upgraded the stock, which is currently trading at a 31% discount to their target despite a 124% increase over the past year. While one narrative suggests it is 23.4% undervalued with a fair value of $51.00, another view highlights its high P/E ratio of 74.9x, indicating potential overvaluation on current earnings.

Jon Rousseau Sells 220,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock

https://www.marketbeat.com/instant-alerts/jon-rousseau-sells-220000-shares-of-brightspring-health-services-nasdaqbtsg-stock-2026-03-06/
Jon Rousseau, an insider at BrightSpring Health Services (NASDAQ:BTSG), sold 220,000 shares of the company's stock for approximately $9.05 million. This transaction reduced his stake by 17.69%. Despite mixed Q4 fundamentals, with revenue up but EPS missing estimates and a high P/E ratio, the company has received "Buy" ratings from analysts and significant institutional investment, leading to a consensus target price of $44.08.

Lisa Nalley Sells 30,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock

https://www.marketbeat.com/instant-alerts/lisa-nalley-sells-30000-shares-of-brightspring-health-services-nasdaqbtsg-stock-2026-03-06/
Lisa Nalley, an insider at BrightSpring Health Services (NASDAQ:BTSG), recently sold 30,000 shares of the company's stock for $1,234,500, reducing her stake by over 21%. This sale comes amidst mixed fundamentals for the company, including strong revenue growth but an EPS miss, and the stock trading at a high P/E ratio near its 52-week high. Despite the insider sale, institutional investors have significantly increased their holdings, and analysts generally maintain a positive outlook with an average target price of $44.08.
Advertisement

Segall Bryant & Hamill LLC Acquires 42,840 Shares of BrightSpring Health Services, Inc. $BTSG

https://www.marketbeat.com/instant-alerts/filing-segall-bryant-hamill-llc-acquires-42840-shares-of-brightspring-health-services-inc-btsg-2026-03-06/
Segall Bryant & Hamill LLC recently increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 51.7%, purchasing an additional 42,840 shares to now own 125,768 shares valued at approximately $3.72 million. Despite a slight EPS miss last quarter, BrightSpring exceeded revenue expectations and analysts maintain a "Buy" rating with an average target price around $44.08, following several increased price targets from firms like Wells Fargo and Mizuho. The company's stock has seen positive sentiment from analysts and upward earnings estimate revisions.

Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase

https://legaldesire.com/latham-advises-on-brightsprings-secondary-offering-of-common-stock-and-concurrent-share-repurchase/
Latham & Watkins LLP advised on BrightSpring Health Services, Inc.'s secondary offering of 20,000,000 shares of common stock at US$41.15 per share by certain selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. BrightSpring itself is not selling shares in this offering, and all proceeds will go to the selling stockholders. The offering is expected to close on March 4, 2026, with Latham's Capital Markets team, led by partners Marc Jaffe, Ian Schuman, and Kaj Nielsen, representing the underwriter.

Surging Earnings Estimates Signal Upside for BrightSpring Health Services, Inc. (BTSG) Stock

https://finviz.com/news/331304/surging-earnings-estimates-signal-upside-for-brightspring-health-services-inc-btsg-stock
BrightSpring Health Services, Inc. (BTSG) is showing significant upside potential due to remarkably improving earnings outlooks and rising analyst optimism. The company has a Zacks Rank #1 (Strong Buy) indicating expected outperformance, with strong upward revisions in consensus estimates for both the upcoming quarter and the full year. This positive trend, correlated with near-term stock price movements, suggests further gains for investors.

BrightSpring Health Services (NASDAQ:BTSG) Upgraded by Zacks Research to "Strong-Buy" Rating

https://www.marketbeat.com/instant-alerts/brightspring-health-services-nasdaqbtsg-upgraded-by-zacks-research-to-strong-buy-rating-2026-03-05/
Zacks Research has upgraded BrightSpring Health Services (NASDAQ:BTSG) from a "hold" to a "strong-buy" rating, joining other analysts who have issued positive ratings and price target increases, leading to a consensus "Buy" rating and a target of $44.08. The company reported $3.55 billion in revenue (up 29.3% year-over-year) but narrowly missed EPS estimates at $0.33. Institutional investors are also showing increased interest in BTSG, with several firms raising or establishing new positions.

Royce & Associates LP Buys 44,505 Shares of BrightSpring Health Services, Inc. $BTSG

https://www.marketbeat.com/instant-alerts/filing-royce-associates-lp-buys-44505-shares-of-brightspring-health-services-inc-btsg-2026-03-05/
Royce & Associates LP significantly increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 32.2%, acquiring an additional 44,505 shares, bringing their total to 182,538 shares worth approximately $5.4 million. This move comes despite a recent large secondary offering by existing shareholders, which will increase the stock's float. The article also highlights strong bullish sentiment from Wall Street analysts, with several firms raising price targets and a consensus "Moderate Buy" rating, following BrightSpring's 29.3% year-over-year revenue growth.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement